Cargando…
Farnesylthiosalicylic acid-derivatized PEI-based nanocomplex for improved tumor vaccination
Cancer vaccines that make use of tumor antigens represent a promising therapeutic strategy by stimulating immune responses against tumors to generate long-term anti-tumor immunity. However, vaccines have shown limited clinical efficacy due to inefficient delivery. In this study, we focus on vaccine...
Autores principales: | Chen, Yuang, Huang, Yixian, Huang, Haozhe, Luo, Zhangyi, Zhang, Ziqian, Sun, Runzi, Wan, Zhuoya, Sun, Jingjing, Lu, Binfeng, Li, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517092/ https://www.ncbi.nlm.nih.gov/pubmed/34703645 http://dx.doi.org/10.1016/j.omtn.2021.09.006 |
Ejemplares similares
-
Engineering a folic acid-decorated ultrasmall gemcitabine nanocarrier for breast cancer therapy: Dual targeting of tumor cells and tumor-associated macrophages
por: Moharil, Pearl, et al.
Publicado: (2022) -
Farnesylthiosalicylic acid sensitizes hepatocarcinoma cells to artemisinin derivatives
por: Wu, Liping, et al.
Publicado: (2017) -
Functionalized Folate-Modified Graphene Oxide/PEI siRNA Nanocomplexes for Targeted Ovarian Cancer Gene Therapy
por: Wang, Yunfei, et al.
Publicado: (2020) -
Improved antitumor activity against prostate cancer via synergistic targeting of Myc and GFAT-1
por: Zhang, Yue, et al.
Publicado: (2023) -
Farnesylthiosalicylic Acid-Loaded Albumin Nanoparticle Alleviates Renal Fibrosis by Inhibiting Ras/Raf1/p38 Signaling Pathway
por: Huang, Hui, et al.
Publicado: (2021)